MENA: Pharma Middle East and Africa’s Pharma Economy to Achieve 38.8 Billion Dollars by 2021
Editor: Ahlam Rais
Based on last year’s sales, Saudi Arabia remains the biggest pharma market in the region followed by Turkey, Egypt and the UAE. Across the MENA region, the total pharma sales have reached 32 billion dollars.
The increasing populations in Sub-Saharan African countries and the development of healthcare systems in the Middle East are providing robust growth opportunities for the pharma sector.
(Source: Deposit Photos)
Amsterdam/The Netherlands – Favourable market conditions are driving increased growth across the Middle East and North Africa (MENA) pharma market – ageing and gentrifying populations, increased healthcare spending, and a modernising supply chain are transforming prospects in the region, according to Cphi Mea.
Total pharma sales have reached an impressive 32 billion dollars across MENA as a whole – the Middle East accounts for 20.3 billion dollars and North Africa 10.7 billion dollars. The increasingly gentrified populations in Sub-Saharan African countries and the development of sophisticated universal healthcare systems in the Middle East are providing robust growth opportunities.
In particular, the finished dosage formulation sector is expanding particularly quickly in the Middle East, with a number of plants being commissioned in the last few years. In the UAE, the government also fast-tracks approval of locally manufactured drugs, which is helping to establish a new manufacturing base in the country – with the added potential for exports to the Gulf Cooperation Council.
Cara Turner, Brand Director – CphI Middle East & Africa, UBM, added, “Many companies are receiving a direct boost from government policy changes and are building new manufacturing facilities in the region, which is seeing the sector perform strongly. Domestic production accounts for approximately 45 % of drug consumption in the Middle East, with generics in the GCC alone valued at 1.55 billion dollars in 2016.”
Saudi Arabia remains the biggest pharma market in the region according to 2017 sales numbers at 7.5 billion dollars, with Turkey (6.9 billion dollars), Egypt (3.4 billion dollars) and the UAE (3.17 billion dollars) following closely behind. However, overall the North Africa region is predicted to see the fastest growth rates in the next few years at 7.6 % CAGR.
Unfold for details of your consent
Stand vom 23.03.2021
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planckstr. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://support.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.